首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿胶酶解液相对分子质量分布及其补血升白作用
引用本文:庞萌萌,李敏,田晨颖,王垒,王升光,于海涛,刘国飞,柏道鸣,高鹏,代龙.阿胶酶解液相对分子质量分布及其补血升白作用[J].中国实验方剂学杂志,2017,23(12):13-17.
作者姓名:庞萌萌  李敏  田晨颖  王垒  王升光  于海涛  刘国飞  柏道鸣  高鹏  代龙
作者单位:山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355,安徽生物肽产业研究院有限公司, 合肥 230000,安徽生物肽产业研究院有限公司, 合肥 230000,山东中医药大学, 济南 250355,山东中医药大学, 济南 250355
基金项目:山东省重点研发计划项目(2015GSF119012)
摘    要:目的:研究阿胶酶解液的相对分子质量分布及其补血、升白的作用。方法:采用TSK-GEL G2000SWXL色谱柱(7.8 mm×300 mm,5μm),流动相0.1 mol·L~(-1)NaCl+0.05%NaN_3+0.1 mol·L~(-1)磷酸盐缓冲液(pH 6.7),流速0.5 m L·min~(-1),检测波长280 nm,对阿胶原液、阿胶仿生酶解液、阿胶胰蛋白酶酶解液进行相对分子质量分布的测定;采用放血法致小鼠血虚模型及环磷酰胺致小鼠白细胞减少模型,观察阿胶酶解液的补血升白作用。结果:阿胶所含蛋白及多肽的相对分子质量6.64×10~4Da,胰蛋白酶酶解液及仿生酶解液的相对分子质量主要集中在3.7×10~3Da左右;阿胶仿生酶解液及胰蛋白酶酶解液可使血虚模型小鼠血红蛋白(Hb),红细胞计数(RBC)水平显著提高,使白细胞减少模型小鼠的白细胞计数(WBC),RBC和Hb水平显著提高。结论:阿胶经酶解后相对分子质量减小且具有显著的补血升白作用,胰蛋白酶酶解与仿生酶解效力大致相当。

关 键 词:阿胶  酶解液  相对分子质量  补血  白细胞计数  红细胞计数  血红蛋白
收稿时间:2017/1/2 0:00:00

Distribution of Relative Molecular Mass of Asini Corii Colla Hydrolyzate and Investigation of Its Blood Enrichment and Leukogenic Effect
PANG Meng-meng,LI Min,TIAN Chen-ying,WANG Lei,WANG Sheng-guang,YU Hai-tao,LIU Guo-fei,BAI Dao-ming,GAO Peng and DAI Long.Distribution of Relative Molecular Mass of Asini Corii Colla Hydrolyzate and Investigation of Its Blood Enrichment and Leukogenic Effect[J].China Journal of Experimental Traditional Medical Formulae,2017,23(12):13-17.
Authors:PANG Meng-meng  LI Min  TIAN Chen-ying  WANG Lei  WANG Sheng-guang  YU Hai-tao  LIU Guo-fei  BAI Dao-ming  GAO Peng and DAI Long
Institution:Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China,Anhui Biological Peptide Industry Research Institute Co. Ltd., Hefei 230000, China,Anhui Biological Peptide Industry Research Institute Co. Ltd., Hefei 230000, China,Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China and Shandong University of Traditional Chinese Medicine, Ji''nan 250355, China
Abstract:Objective: To study on distribution of relative molecular mass of Asini Corii Colla hydrolyzate and discuss its blood enrichment and leukogenic effect. Method: TSK-GEL G2000SWXL column (7.8 mm×300 mm) was employed,mobile phase was consisted of 0.1 mol·L-1 NaCl+0.05% NaN3+0.1 mol·L-1 phosphate buffer solution (pH 6.7) and detection wavelength was set at 280 nm;distributions of relative molecular mass of Asini Corii Colla concentrate,bionic hydrolysate and trypsin hydrolysate were determined.The bloodletting method was adopted to establish blood deficiency mice model,leukopenia model induced by cyclophosphamide in mice were used,blood enrichment and leukogenic effect of Asini Corii Colla hydrolyzate was observed. Result: Relative molecular mass of protein and polypeptide in Asini Corii Colla was greater than 6.64×104 Da,relative molecular mass of bionic hydrolysate and trypsin hydrolysate of Asini Corii Colla mainly concentrated in about 3.7×103 Da.Bionic hydrolysate and trypsin hydrolysate of Asini Corii Colla could significantly improve hemoglobin (Hb) andred cell count (RBC)of blood deficiency model mice,and they could significantly increase white blood cell count (WBC),RBC and Hb levels of leukopenia model mice. Conclusion: After the enzymolysis,relative molecular mass of Asini Corii Colla decreases and its blood enrichment and leukogenic effect is significant,effect of bionic hydrolysate and trypsin hydrolysate is roughly equivalent.
Keywords:Asini Corii Colla  hydrolysate  relative molecular mass  blood enrichment  white blood cell count  red cell count  hemoglobin
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号